Tofacitinib Approved for New Ankylosing Spondylitis Indication

The action makes the drug the first Janus kinase (JAK) inhibitor to be approved for ankylosing spondylitis.

Related Keywords

,Pfizer ,Assessment In Spondyloarthritis International Society ,Drug Administration ,Spondyloarthritis International Society ,Ankylosing Spondylitis ,Ankylosing Spondylitis Bechterews Disease ,Rheumatoid Arthritis ,A ,Ulcerative Colitis ,Psoriatic Arthritis ,Anti Tnf ,Anti Tumor Necrosis Factor ,Biologic Therapy ,Immunomodulator ,Lenalidomide ,Activism ,Activist ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Social Issues ,Myocardial Infarction ,Cancer ,Alignant Neoplasia ,Arcinoma ,Stroke ,